Announced
Completed
Financials
Tags
Minority
Biotechnology
Private
Friendly
Single Bidder
biotechnology company
United Kingdom
Acquisition
Cross Border
Completed
Venture Capital
Private Equity
Synopsis
Flerie Invest, an investment firm, and Tencent led a $67m Series B round in Microbiotica, a biotechnology company, with participation from Cambridge Innovation Capital, IP Group and Seventure Partners. “Microbiotica is a highly innovative UK company operating in the very important field of microbiome biology. Through its bioinformatics platform, it is generating therapeutic treatments targeting immuno-oncology and ulcerative colitis. It has a number of drug development programmes that are progressing to clinical trials. British Patient Capital, through our Future Fund: Breakthrough programme, is proud to support this world-class team as they continue to explore and commercialise this exciting new area of medicine," Judith Hartley, British Patient Capital CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.